A novel role for protein arginine deiminase 4 in pluripotency: The emerging role of citrullinated histone H1 in cellular programming

BioEssays

Volumn 36, Issue 8, 2014, Pages 736-740

  Slade, Daniel J ^a   Horibata, Sachi ^b   Coonrod, Scott A ^b   Thompson, Paul R ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b Department of Obstetrics Gynecology   (United States)

Author keywords

Cancer; Chromatin; Deiminase; Gene regulation; Histone; Pluripotency; Rheumatoid arthritis; Stem cells

Indexed keywords

ARGININE DEIMINASE 4; HISTONE H1; PROTEIN ARGININE DEIMINASE; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CITRULLINE; HISTONE; HYDROLASE; PEPTIDYLARGININE DEIMINASE TYPE IV;

ARTICLE; CHEMICAL REACTION; CHROMATIN STRUCTURE; CITRULLINATION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; IMMUNOCOMPETENT CELL; MODULATION; NONHUMAN; NUCLEAR REPROGRAMMING; PLURIPOTENT STEM CELL; PROMOTER REGION; PROTEIN PROCESSING; UPREGULATION; ANIMAL; CHROMATIN ASSEMBLY AND DISASSEMBLY; ENZYMOLOGY; GENETICS; METABOLISM; PHYSIOLOGY; RHEUMATOID ARTHRITIS;

ANIMALS; ARTHRITIS, RHEUMATOID; CELLULAR REPROGRAMMING; CHROMATIN ASSEMBLY AND DISASSEMBLY; CITRULLINE; HISTONES; HUMANS; HYDROLASES; INDUCED PLURIPOTENT STEM CELLS; PROTEIN PROCESSING, POST-TRANSLATIONAL; TRANSCRIPTION FACTORS; TRANSCRIPTION, GENETIC;

EID: 84904039654     PISSN: 02659247     EISSN: 15211878     Source Type: Journal    
DOI: 10.1002/bies.201400057     Document Type: Article

References (46)

1. Bicker KL, Thompson PR. 2013. The protein arginine deiminases: structure, function, inhibition, and disease. Biopolymers 99: 155-63.
2. Raijmakers R, Zendman AJ, Egberts WV, Vossenaar ER, et al. 2007. Methylation of arginine residues interferes with citrullination by peptidylarginine deiminases in vitro. J Mol Biol 367: 1118-29.
3. Slack JL, Jones LE, Jr., Bhatia MM, Thompson PR. 2011. Autodeimination of protein arginine deiminase 4 alters protein-protein interactions but not activity. Biochemistry 50: 3997-4010.
4. Christophorou MA, Castelo-Branco G, Halley-Stott RP, Oliveira CS, et al. 2014. Citrullination regulates pluripotency and histone H1 binding to chromatin. Nature 507: 104-8.
5. Mohanan S, Cherrington BD, Horibata S, McElwee JL, et al. 2012. Potential role of peptidylarginine deiminase enzymes and protein citrullination in cancer pathogenesis. Biochem Res Int 2012: 895343.
6. Schellekens GA, de Jong BA, van den Hoogen FH, van de Putte LB, et al. 1998. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J Clin Invest 101: 273-81.
7. Knight JS, Zhao W, Luo W, Subramanian V, et al. 2013. Peptidylarginine deiminase inhibition is immunomodulatory and vasculoprotective in murine lupus. J Clin Invest 123: 2981-93.
8. Chen CC, Isomoto H, Narumi Y, Sato K, et al. 2008. Haplotypes of PADI4 susceptible to rheumatoid arthritis are also associated with ulcerative colitis in the Japanese population. Clin Immunol 126: 165-71.
9. Knight JS, Luo W, O'Dell AA, Yalavarthi S, et al. 2014. Peptidylarginine deiminase inhibition reduces vascular damage and modulates innate immune responses in murine models of atherosclerosis. Circ Res 114: 947-56.
10. Chumanevich AA, Causey CP, Knuckley BA, Jones JE, et al. 2011. Suppression of colitis in mice by Cl-amidine: a novel peptidylarginine deiminase inhibitor. Am J Ph Gastrointest Liver Physiol 300: G929-38.
11. McElwee JL, Mohanan S, Griffith OL, Breuer HC, et al. 2012. Identification of PADI2 as a potential breast cancer biomarker and therapeutic target. BMC Cancer 12: 500.
12. Musse AA, Li Z, Ackerley CA, Bienzle D, et al. 2008. Peptidylarginine deiminase 2 (PAD2) overexpression in transgenic mice leads to myelin loss in the central nervous system. Dis Model Mech 1: 229-40.
13. Jones JE, Causey CP, Knuckley B, Slack-Noyes JL, et al. 2009. Protein arginine deiminase 4 (PAD4): current understanding and future therapeutic potential. Curr Opin Drug Discov Devel 12: 616-27.
14. Fan LY, He DY, Wang Q, Zong M, et al. 2012. Citrullinated vimentin stimulates proliferation, pro-inflammatory cytokine secretion, and PADI4 and RANKL expression of fibroblast-like synoviocytes in rheumatoid arthritis. Scand J Rheumatol 41: 354-8.
15. Bay-Jensen AC, Karsdal MA, Vassiliadis E, Wichuk S, et al. 2013. Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. Arthritis Rheum 65: 972-80.
16. Okumura N, Haneishi A, Terasawa F. 2009. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin. Clin Chim Acta 401: 119-23.
17. Shelef MA, Bennin DA, Mosher DF, Huttenlocher A. 2012. Citrullination of fibronectin modulates synovial fibroblast behavior. Arthritis Res Ther 14: R240.
18. Harre U, Georgess D, Bang H, Bozec A, et al. 2012. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 122: 1791-802.
19. Sokolove J, Zhao X, Chandra PE, Robinson WH. 2011. Immune complexes containing citrullinated fibrinogen costimulate macrophages via Toll-like receptor 4 and Fcgamma receptor. Arthritis Rheum 63: 53-62.
20. Leshner M, Wang S, Lewis C, Zheng H, et al. 2012. PAD4 mediated histone hypercitrullination induces heterochromatin decondensation and chromatin unfolding to form neutrophil extracellular trap-like structures. Front Immunol 3: 307.
21. Sharma P, Azebi S, England P, Christensen T, et al. 2012. Citrullination of histone H3 interferes with HP1-mediated transcriptional repression. PLoS Genet 8: e1002934.
22. Dwivedi N, Neeli I, Schall N, Wan H, et al. 2014. Deimination of linker histones links neutrophil extracellular trap release with autoantibodies in systemic autoimmunity. FASEB J, in press, doi: 10.1096/fj.13-247254
23. Li P, Li M, Lindberg MR, Kennett MJ, et al. 2010. PAD4 is essential for antibacterial innate immunity mediated by neutrophil extracellular traps. J Exp Med 207: 1853-62.
24. Wang Y, Li M, Stadler S, Correll S, et al. 2009. Histone hypercitrullination mediates chromatin decondensation and neutrophil extracellular trap formation. J Cell Biol 184: 205-13.
25. Dwivedi N, Radic M. 2014. Citrullination of autoantigens implicates NETosis in the induction of autoimmunity. Ann Rheum Dis 73: 483-91.
26. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, Gizinski A, et al. 2013. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 5: 178ra40.
27. Hakkim A, Furnrohr BG, Amann K, Laube B, et al. 2010. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc Natl Acad Sci USA 107: 9813-8.
28. Savchenko AS, Inoue A, Ohashi R, Jiang S, et al. 2011. Long pentraxin 3 (PTX3) expression and release by neutrophils in vitro and in ulcerative colitis. Pathol Int 61: 290-7.
29. Borissoff JI, Joosen IA, Versteylen MO, Brill A, et al. 2013. Elevated levels of circulating DNA and chromatin are independently associated with severe coronary atherosclerosis and a prothrombotic state. Arterioscler Thromb Vasc Biol 33: 2032-40.
30. Demers M, Krause DS, Schatzberg D, Martinod K, et al. 2012. Cancers predispose neutrophils to release extracellular DNA traps that contribute to cancer-associated thrombosis. Proc Natl Acad Sci USA 109: 13076-81.
31. Mohanan S, Horibata S, McElwee JL, Dannenberg AJ, et al. 2013. Identification of macrophage extracellular trap-like structures in mammary gland adipose tissue: a preliminary study. Front Immunol 4: 67.
32. Hagiwara T, Nakashima K, Hirano H, Senshu T, et al. 2002. Deimination of arginine residues in nucleophosmin/B23 and histones in HL-60 granulocytes. Biochem Biophys Res Commun 290: 979-83.
33. Cuthbert GL, Daujat S, Snowden AW, Erdjument-Bromage H, et al. 2004. Histone deimination antagonizes arginine methylation. Cell 118: 545-53.
34. Wang Y, Wysocka J, Sayegh J, Lee YH, et al. 2004. Human PAD4 regulates histone arginine methylation levels via demethylimination. Science 306: 279-83.
35. Yao H, Li P, Venters BJ, Zheng S, et al. 2008. Histone Arg modifications and p53 regulate the expression of OKL38, a mediator of apoptosis. J Biol Chem 283: 20060-8.
36. Li P, Yao H, Zhang Z, Li M, et al. 2008. Regulation of p53 target gene expression by peptidylarginine deiminase 4. Mol Cell Biol 28: 4745-58.
37. Liu GY, Liao YF, Chang WH, Liu CC, et al. 2006. Overexpression of peptidylarginine deiminase IV features in apoptosis of haematopoietic cells. Apoptosis 11: 183-96.
38. Zhang X, Bolt M, Guertin MJ, Chen W, et al. 2012. Peptidylarginine deiminase 2-catalyzed histone H3 arginine 26 citrullination facilitates estrogen receptor alpha target gene activation. Proc Natl Acad Sci USA 109: 13331-6.
39. Gaspar-Maia A, Alajem A, Meshorer E, Ramalho-Santos M. 2011. Open chromatin in pluripotency and reprogramming. Nat Revi Mol Cell Biol 12: 36-47.
40. Okita K, Ichisaka T, Yamanaka S. 2007. Generation of germline-competent induced pluripotent stem cells. Nature 448: 313-7.
41. Luo Y, Arita K, Bhatia M, Knuckley B, et al. 2006. Inhibitors and inactivators of protein arginine deiminase 4: functional and structural characterization. Biochemistry 45: 11727-36.
42. Jones JE, Slack JL, Fang P, Zhang X, et al. 2012. Synthesis and screening of a haloacetamidine containing library to identify PAD4 selective inhibitors. ACS Chem Biol 7: 160-5.
43. Wong LH, McGhie JD, Sim M, Anderson MA, et al. 2010. ATRX interacts with H3.3 in maintaining telomere structural integrity in pluripotent embryonic stem cells. Genome Res 20: 351-60.
44. Leitch HG, McEwen KR, Turp A, Encheva V, et al. 2013. Naive pluripotency is associated with global DNA hypomethylation. Nat Struct Mol Biol 20: 311-6.
45. Hu G, Kim J, Xu Q, Leng Y, et al. 2009. A genome-wide RNAi screen identifies a new transcriptional module required for self-renewal. Genes Dev 23: 837-48.
46. Zhang Y, Cooke M, Panjwani S, Cao K, et al. 2012. Histone h1 depletion impairs embryonic stem cell differentiation. PLoS Genet 8: e1002691.